
[Picower News, David Orenstein | March 11, 2023] On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1, as the first drug available to treat Rett syndrome. The original research showing that IGF-1 could treat Rett syndrome was published by MIT in 2009. Rett syndrome is a […]